KidStrong, a science-backed training program for children ages walking to 11 years old, hosted its grand opening for a new location in Woodway.

ATyr on Monday said the Phase 3 study of efzofitimod in the interstitial lung disease pulmonary sarcoidosis missed its primary endpoint of change from baseline in daily steroid doses at 48 weeks.